Variable | Control group | PCI group | CABG group |
---|---|---|---|
N | 47 | 64 | 57 |
Age (year) | 63.17 ± 8.34 | 62.13 ± 9.81 | 65 ± 8.34 |
Gender | M 54.55%, F 45.45% | M 56.25%, F 43.75% | M 52.63%, F 47.37% |
LVEF | 60.32 ± 8.63% | 57.62 ± 10.27% | 59.48 ± 10.27% |
BMI | 27.35 ± 1.65 | 27.83 ± 1.83 | 28.47 ± 1.93 |
CrCl | 75.71 ± 9.55 | 73.83 ± 15.27 | 74.64 ± 9.23 |
TC mmol/L | 5.47 ± 1.25 | 5.34 ± 0.97 | |
TG mmol/l | 1.83 ± 0.89 | 1.68 ± 0.56 | |
LDL-c mmol/l | 3.5 ± 0.93 | 3.42 ± 0.81 | |
Aspirin | 97% | 98% | 96% |
Statin | 88% | 92% | 89% |
CCB | 55% | 33% | 35% |
ACEI | 55% | 70% | 67% |
BB | 77% | 81% | 83% |
Other | 20% | 33% | 37% |